Skip to main content
. 2022 Jul 20;2(3):100075. doi: 10.1016/j.xagr.2022.100075

Table 2.

Maternal outcomes of labor in study population

Serial no. Maternal parameters Study group Control group P value
n=136 n=135
1 Mode of delivery, n (%)
 Normal delivery 127 (93.4) 103 (76.3) .0001a
 Operative vaginal delivery 7 (5.14) 8 (5.9) .779a
 CD 2 (1.5%)b 24 (17.8)c .000002d
Total 136 135
2 Complications,e n (%)
 PPH 1 (0.9) 1 (0.9) 1d
 Infection 0 (0) 1 (0.9)e .498d
Total 1 (0.9) 2 (1.8) .622d
3 After delivery
 Hb (gram%) 9.940±1.220 9.644±1.096 .037f
 Total leucocyte count (cells/mL) 10,316.88±2383.90 10,553.46±2244.30 .401f
4 Duration of hospital stay (d), mean±SD 2.014±1.092 2.210±1.170 .155f
5 Oxytocin used 25 (18.4) 70 (51.8) .000000008a
n=134g n=111g
6 Duration of active phase of labor (h), mean±SD 2.27±1.44 4.12±1.60 .0000000000000000019f
7 Second stage of labor (min), mean±SD 28.01±16.70 31.10±18.50 .171f

CD, cesarean delivery; PPH, postpartum hemorrhage; SD, standard deviation.

a

Chi-squared test

b

Study group: Of 2 CDs, the indications were arrest of labor and arrest of the second stage of labor

c

Control group: Of 24 CDs, 12 (50%) were performed for arrest of labor in the active phase, 3 (12.5%) were performed for second–stage arrest, and 9 (37.5%) were performed for fetal distress

d

Fisher exact test

e

Atonic PPH in 1 in each group, which was medically managed. Of note, 1 case in the control group had malarial infection

f

Independent t test

g

Of note, 2 women in the study group and 24 women in the control group underwent CD.

Pandey. Reduction of primary cesarean delivery by use of World Health Organization Labor Care Guide. Am J Obstet Gynecol Glob Rep 2022.